2OAG image
Entry Detail
PDB ID:
2OAG
Title:
Crystal structure of human dipeptidyl peptidase IV (DPPIV) with pyrrolidine-constrained phenethylamine 29g
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2006-12-15
Release Date:
2007-09-11
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.24
R-Value Work:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Dipeptidyl peptidase 4
Chain IDs:A, B, C, D
Chain Length:726
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.
Bioorg.Med.Chem.Lett. 17 2005 2012 (2007)
PMID: 17276063 DOI: 10.1016/j.bmcl.2007.01.026

Abstact

A novel series of pyrrolidine-constrained phenethylamines were developed as dipeptidyl peptidase IV (DPP4) inhibitors for the treatment of type 2 diabetes. The cyclohexene ring of lead-like screening hit 5 was replaced with a pyrrolidine to enable parallel chemistry, and protein co-crystal structural data guided the optimization of N-substituents. Employing this strategy, a >400x improvement in potency over the initial hit was realized in rapid fashion. Optimized compounds are potent and selective inhibitors with excellent pharmacokinetic profiles. Compound 30 was efficacious in vivo, lowering blood glucose in ZDF rats that were allowed to feed freely on a mixed meal.

Legend

Protein

Chemical

Disease

Primary Citation of related structures